RESTASIS Class Action Lawsuit

Anyone who used Restasis® between May 1, 2015 and July 31, 2021, may be eligible to receive money from a class action lawsuit over the price of the eye drop.

Attorneys have reached a proposed settlement with Allergan, the maker of Restasis. The lawsuit is on behalf of both consumers and third-party payers.

The defendant denies any wrongdoing. Notably, the lawsuit has nothing to do with the safety of Restasis.

“Consumers” includes anyone who purchased Restasis for their own use, in a pharmacy or online pharmacy, in one of some 32 states and the District of Columbia. Click here to learn if you are eligible.

Other restrictions apply.

You may ask to be excluded from the class action, but must do so by objecting to the class action by June 7, 2022.

Allergan has agreed to pay $29,999,999.99 into a fund to settle all claims and attorney fees.

Claims must be submitted online or postmarked by August 11, 2022.

For more information, visit www.restasislitigation.com or call 877-868-6810.

More About Restasis and Allergan

Since Allergan’s patent protection for Restasis ended several years ago, several companies have entered the Dry Eye market with drops that contain cyclosporine, the active ingredient in Restasis. These newer drops have different formulations than Restasis. Sometimes the concentration of cyclosporine is different and sometimes the vehicle, the liquid in which cyclosporine is suspended, is different. A generic version of the drug is also now available. For information on effectiveness, check the medication’s product information sheet. You can find the product sheet for Restasis here.

Allergan tried to delay competition for Restasis by selling its Restasis patent in 2017 to the Saint Regis Mohawk Tribe in New York. Attempts to protect the patient failed when in 2019, the U.S. Supreme Court rejected Allergan’s argument that the sovereign status of the tribe shielded the Restasis patent from U.S. Patent and Trademark Law.

Reference

Allergan loses Supreme Court fight to shield Restasis patents with Native American tribe
April 15, 2109
View the full report.

 

Support Not A Dry Eye Foundation. When you shop at smile.amazon.com, Amazon donates 0.5% of your purchase.